These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6236187)

  • 21. Biochemistry of reduction of nitro heterocycles.
    Biaglow JE; Varnes ME; Roizen-Towle L; Clark EP; Epp ER; Astor MB; Hall EJ
    Biochem Pharmacol; 1986 Jan; 35(1):77-90. PubMed ID: 2934068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of misonidazole on formation of thymine damage by gamma rays.
    Remsen JF
    Radiat Res; 1985 Feb; 101(2):306-11. PubMed ID: 3975359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metronidazole (Flagyl), misonidazole (Ro 07-0582), iron, zinc and sulphur compounds in cancer therapy.
    Bahnemann D; Basaga H; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():16-9. PubMed ID: 277218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: quantitative differences found using the radiation sensitizing agent misonidazole or oxygen.
    Koch CJ; Stobbe CC; Bump EA
    Radiat Res; 1984 Apr; 98(1):141-53. PubMed ID: 6718689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial respiratory chain features after gamma-irradiation.
    Battino M; Ferri E; Gattavecchia E; Breccia A; Genova ML; Littarru GP; Lenaz G
    Free Radic Res; 1997 May; 26(5):431-8. PubMed ID: 9179588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma irradiation of pharmaceutical compounds, nitroimidazoles, as a new alternative for water treatment.
    Sánchez-Polo M; López-Peñalver J; Prados-Joya G; Ferro-García MA; Rivera-Utrilla J
    Water Res; 2009 Sep; 43(16):4028-36. PubMed ID: 19541339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen depletion in irradiated aqueous solutions containing electron affinic hypoxic cell radiosensitizers.
    Michaels HB
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1055-8. PubMed ID: 3744926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting effects of cytochrome C on the radiosensitivity of single-stranded phi X174 DNA in the presence of misonidazole or phenol under anoxia.
    Lafleur MV; Pluijmackers-Westmijze EJ; Loman H
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1195-7. PubMed ID: 6088446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against light-activated photofrin II killing of tumor cells by nitroimidazoles.
    Santus R; Stobbe CC; McPhee MS; Chapman JD
    Radiat Res; 1992 Apr; 130(1):31-7. PubMed ID: 1532856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the radiosensitizers metronidazole and misonidazole (RO-07-0582) with bovine serum albumin. Effect of urea and ionic strength.
    Sułkowska A; Lubas B; Wilczok T
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Aug; 46(2):169-79. PubMed ID: 6332091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of delayed hypersensitivity by metronidazole and misonidazole.
    Rockwell S; Irvin CG; Neaderland MH
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):701-6. PubMed ID: 6222020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA; Herman TS; Holden SA; Jones SM
    J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxic cell radiosensitizers--present and future.
    Wasserman TH
    Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):849-52. PubMed ID: 6457019
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs.
    Rao DN; Mason RP
    J Biol Chem; 1987 Aug; 262(24):11731-6. PubMed ID: 2887562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
    Adams GE; Stratford IJ
    Biochem Pharmacol; 1986 Jan; 35(1):71-6. PubMed ID: 2934067
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro.
    Anderson RF; Patel KB
    Br J Cancer; 1979 Jun; 39(6):705-10. PubMed ID: 109112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic studies of four types of nitroheterocyclic radicals by pulse radiolysis. Correlation of pharmacological properties to decay rates.
    Guissani A; Henry Y; Lougmani N; Hickel B
    Free Radic Biol Med; 1990; 8(2):173-89. PubMed ID: 2332194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM; Chin J; Marchow L; Paciga J
    Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799.
    Dische S; Saunders MI; Dunphy EP; Bennett MH; Des Rochers C; Stratford MR; Minchinton AI; Orchard RA
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1109-11. PubMed ID: 2943708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of nitroimidazoles in model chemical and biological systems.
    Wardman P; Anderson RF; Clarke ED; Jones NR; Minchinton AI; Patel KB; Stratford MR; Watts ME
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):777-80. PubMed ID: 7050044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.